Many people notice reduced hyperpigmentation, fewer dark spots, and a natural, radiant glow after consistent treatments
Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive weekly subcutaneous injections of either CagriSema or Tirzepatide, with a dose escalation period followed by maintenance dosing Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
Heres what to do: Advertisement While the idea of giving yourself a subcutaneous injection can be scary at first, your healthcare provider will work with you to answer any questions and make sure you feel comfortable
Br J Pharmacol 138(7):12071209
skin regeneration amd wound healing
Nevertheless, an increasing amount of evidence suggests that in contrast to the destruction caused by high levels of ROS, at moderate levels, ROS play central roles as second messengers in modifying a variety of signaling molecules to regulate inflammation [6]